SENS
The Newsroom
In The Media
Leadership & Structure
Corporate Governance
Our Heritage
Diversity
Learning & Development
Optimise Your Health
Medicine Safety
Package Inserts
Any Queries? Contact Us
Brand News
Brands At A Glance
Our Commitment
Product Finder
Single Exit Price
The Investment Case
Financial Reports
Financial Indicators
Shareholder Corner
Contact Investor Relations
SENS
Celebrating 120 Years
Our Latest Initiatives
Require Funding?
Contact Us
Thank you for accessing Adcock Ingram's corporate website. Our website offers a diverse range of information about our Company to help give you an understanding of who we are and what we have to offer.
Please
contact us
should you require any further information.
Jonathan Louw (CEO Adcock Ingram)
Interim Results 2010
Interim Results Presentation 2010
Interim Results Webcast 2010
MSD,a tradename of Merck & Co., Inc, and Adcock Ingram today announced a five-year strategic collaboration to co-promote and distribute a number of established MSD products.
[READ MORE]
catı kaplama
catı aktarma
catı tamiri
kiremit aktarma
v-pills
pagerank
film izle
Latest Share Price
6130 cents
Percentage Change:
0.92
Code:
AIP
PE Ratio:
13.07
EY:
7.65
DY:
2.57
ZAR/USD:
7.2085
Interim Dividend
(cents):
80.00
Final Dividend
(cents):
78.00